| Enrollment Model Type | Coeff Tag | Year | Weight Score |
|---|---|---|---|
| CFA | HCC49 |
2026 | + 2.833 |
| CFD | HCC49 |
2026 | + 6.399 |
| CNA | HCC49 |
2026 | + 9.256 |
| CND | HCC49 |
2026 | + 13.778 |
| CPA | HCC49 |
2026 | + 3.269 |
| CPD | HCC49 |
2026 | + 7.771 |
| INS | HCC49 |
2026 | + 1.528 |
The following diagnoses map directly to HCC 49 under the V28 risk adjustment model:
| ICD-10 Code | Clinical Diagnosis Description | Guideline |
|---|---|---|
| E74.02 | Pompe disease | Notes ↗ |
| E75.21 | Fabry (-Anderson) disease | Notes ↗ |
| E75.22 | Gaucher disease | Notes ↗ |
| E76.01 | Hurler's syndrome | Notes ↗ |
| E76.02 | Hurler-Scheie syndrome | Notes ↗ |
| E76.03 | Scheie's syndrome | Notes ↗ |
| E76.1 | Mucopolysaccharidosis, type II | Notes ↗ |
| E76.210 | Morquio A mucopolysaccharidoses | Notes ↗ |
| E76.211 | Morquio B mucopolysaccharidoses | Notes ↗ |
| E76.219 | Morquio mucopolysaccharidoses, unspecified | Notes ↗ |
| E76.22 | Sanfilippo mucopolysaccharidoses | Notes ↗ |
| E76.29 | Other mucopolysaccharidoses | Notes ↗ |
| E76.3 | Mucopolysaccharidosis, unspecified | Notes ↗ |